3 ms·
It’s unfair to call treatments untested. Medications are tested extensively. The FDA could work with sponsors to come up with a range of risk profiles and expan
by junofan 3y ago
It’s unfair to call treatments untested. Medications are tested extensively. The FDA could work with sponsors to come up with a range of risk profiles and expand access.
- ejstronge 3y ago> The FDA could work with sponsors to come up with a range of risk profiles and expand access. They indeed do this and have various avenues for treatments to be approved on expedited timelines.
- nine_k 3y agoI agree: not completely untested, but not tested sufficiently to get an FDA approval. They show early promising results. BTW people picking such experimental treatments would provide important data points.